- Report
- March 2024
- 186 Pages
Global
From €3210EUR$3,374USD£2,749GBP
€3567EUR$3,749USD£3,054GBP
- Report
- May 2024
- 146 Pages
Global
From €5185EUR$5,450USD£4,440GBP
- Report
- June 2023
- 165 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- January 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- April 2024
- 190 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- October 2020
- 156 Pages
Global
From €1308EUR$1,375USD£1,120GBP
€2617EUR$2,750USD£2,240GBP
- Report
- April 2021
- 260 Pages
Global
From €2284EUR$2,400USD£1,955GBP
- Report
- April 2024
- 318 Pages
From €5258EUR$5,720USD£4,350GBP
- Report
- August 2022
- 222 Pages
Global
From €3330EUR$3,500USD£2,851GBP
- Report
- February 2023
- 150 Pages
Global
From €5661EUR$5,950USD£4,847GBP
- Report
- September 2022
- 232 Pages
Global
From €3330EUR$3,500USD£2,851GBP
- Report
- March 2022
- 80 Pages
Global
From €904EUR$950USD£774GBP
- Report
- May 2024
- 137 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- August 2022
- 110 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2022
- 210 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- February 2022
- 228 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- January 2022
- 130 Pages
Global
From €6613EUR$6,950USD£5,662GBP
- Report
- December 2022
- 120 Pages
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- January 2023
- 173 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Clinical Trials
- August 2020
- 1756 Pages
Global
From €2379EUR$2,500USD£2,037GBP
The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process.
Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more